Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses

Although many studies provide strong evidence supporting the development of HCV virus-like particle (VLP)-based vaccines, the fact that heterologous viral vectors and/or multiple dosing regimes are required to induce protective immunity indicates that it is necessary to improve their immunogenicity....

Descripción completa

Detalles Bibliográficos
Autores principales: Chua, Brendon Y., Johnson, Douglas, Tan, Amabel, Earnest-Silveira, Linda, Sekiya, Toshiki, Chin, Ruth, Torresi, Joseph, Jackson, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472981/
https://www.ncbi.nlm.nih.gov/pubmed/23091628
http://dx.doi.org/10.1371/journal.pone.0047492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472981/
https://www.ncbi.nlm.nih.gov/pubmed/23091628
http://dx.doi.org/10.1371/journal.pone.0047492

Ejemplares similares